Top

Published in:

01-06-2018 | Original Investigation

Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function

Authors: Masahiko Harada, Satoshi Tabako, Yuichiro Fujii, Yuichi Takarada, Kyoko Hayashi, Hiroshi Ohara, Fumihiko Hara, Takanori Ikeda

Published in: Journal of Echocardiography | Issue 2/2018

Abstract

Background

The left atrial appendage (LAA) flow velocity is an important factor for thrombus formation in patients with non-valvular atrial fibrillation (NV-AF). Recently, the relation of plasma brain natriuretic peptide (BNP) levels and thromboembolism has been reported in patients with NV-AF. The aim of this study was to determine whether the plasma BNP is predictive of lower LAA flow velocity in patients with NV-AF and normal left ventricular (LV) systolic function.

Methods and results

A total of 184 patients with NV-AF (132 men; 65 ± 12 years, LV ejection fraction; 65 ± 10%) underwent transthoracic echocardiography, transesophageal echocardiography (TEE), and measurement of plasma BNP. The LAA flow velocity was obtained by pulsed Doppler TEE. Multivariate logistic regression analysis demonstrated that plasma BNP levels, left atrial volume index (LAVI), LV mass index (LVMI), and the CHADS₂ score were independent predictors of lower LAA flow velocity (< 20 cm/s). Plasma BNP levels (r = − 0.58, p < 0.001) were correlated with LAA flow velocity. The area under the curve (AUC) for BNP (AUC 0.803) was larger than that for the CHADS₂ score (AUC 0.712), LAVI (AUC 0.664) and LVMI (AUC 0.608) with an optimal BNP cut-off value of 164 pg/ml (sensitivity 75.7%, specificity 71.1%).

Conclusions

This study showed that a higher plasma BNP was associated with a lower LAA flow velocity in patients with NV-AF and normal LV systolic function. The plasma BNP may complement the role of the CHADS₂ score in predicting lower LAA flow velocity.

Archer SL, James KE, Kvernen LR, et al. Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. Am Heart J. 1995;130:287–95.CrossRefPubMed

Handke M, Harloff A, Hetzel A, et al. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation—a transesophageal echocardiographic study in 500 patients with cerebral ischemia. J Am Soc Echocardiogr. 2005;18:1366–72.CrossRefPubMed

Igarashi Y, Kashimura K, Makiyama Y, et al. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation in significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J. 2001;65:788–92.CrossRefPubMed

Shimizu H, Murakami Y, Inoue S, et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke. 2002;33:1005–10.CrossRefPubMed

Watanabe D, Shizuka K, Koyama S, et al. Plasma brain natriuretic levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation. Circ J. 2007;71:1446–51.CrossRefPubMed

Tamura H, Watanabe T, Nishiyama S, et al. Elevated plasma brain natriuretic peptide levels predict left atrial appendage dysfunction in patients with acute ischemic stroke. J Cardiol. 2012;60:126–32.CrossRefPubMed

Doukky R, Gage H, Nagarajan V, et al. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013;30:889–95.CrossRefPubMed

Mügge A, Kühn H, Nikutta P, et al. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol. 1994;23:599–607.CrossRefPubMed

Rietbrock S, Heeley E, Plumb J, et al. Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age > 75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J. 2008;156:57–64.CrossRefPubMed

10.

Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–70.CrossRefPubMed

11.

Lester SJ, Ryan EW, Schiller NB, et al. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–32.CrossRefPubMed

12.

Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613–8.CrossRefPubMed

13.

Fatkin D, Herbert E, Feneley MP. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol. 1994;73:672–6.CrossRefPubMed

14.

The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med. 1998;128:639–47.CrossRef

15.

García-Fernández MA, Torrecilla EG, San Román D, et al. Left atrial appendage Doppler flow patterns: implications on thrombus formation. Am Heart J. 1992;124:955–61.CrossRefPubMed

16.

Santiago D, Warshofsky M, Li Mandri G, et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol. 1994;24:159–64.CrossRefPubMed

17.

Li YH, Lai LP, Shyu KG, et al. Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. Chest. 1994;105:748–52.CrossRefPubMed

18.

Donal E, Yamada H. The left atrial appendage, a small, blind-ended structure. A review of its echocardiographic evaluation and its clinical role. Chest. 2005;128:1853–62.CrossRefPubMed

19.

Noda T, Arakawa M, Miwa H, et al. Effects of heart rate on flow velocity of the left atrial appendage in patients with nonvalvular atrial fibrillation. Clin Cardiol. 1996;19:295–300.CrossRefPubMed

20.

Iwama M, Kawasaki M, Tanaka R, et al. Left atrial appendage emptying fraction assessed by a feature-tracking echocardiographic method is a determinant of thrombus in patients with nonvalvular atrial fibrillation. J Cardiol. 2012;59:329–36.CrossRefPubMed

21.

Bansal M, Kasliwal RR. Echocardiography for left atrial appendage structure and function. Indian Heart J. 2012;64:469–75.CrossRefPubMedPubMedCentral

22.

Panagiotopoulos K, Toumanidis S, Saridakis N, et al. Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillation. J Am Soc Echocardiogr. 1998;11:711–9.CrossRefPubMed

23.

Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J. 1972;34:520–5.CrossRefPubMedPubMedCentral

24.

Falk RH. Etiology and complications of atrial fibrillation: insights from pathology studies. Am J Cardiol. 1998;82:10N–7N.CrossRefPubMed

25.

Agmon Y, Khandheria BK, Meissner I, et al. Are left atrial appendage flow velocities adequate surrogates of global left atrial function? A population-based transthoracic and transesophageal echocardiographic study. J Am Soc Echocardiogr. 2002;15:433–40.CrossRefPubMed

26.

Beigel R, Wunderlich NC, Ho SY, et al. The left atrial appendage: anatomy, function, and noninvasive evaluation. J Am Coll Cardiol Imaging. 2014;7:1251–65.CrossRef

27.

Tsang TSM, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol. 2002;40:1636–44.CrossRefPubMed

28.

Tabata T, Oki T, Fukuda N, et al. Influence of left atrial pressure on left atrial appendage flow velocity patterns in patients in sinus rhythm. J Am Soc Echocardiogr. 1996;9:857–64.CrossRefPubMed

29.

Lin JM, Hsu KL, Hwang JJ, et al. Influence of left ventricular diastole on left atrial appendage blood flow in patients with nonrheumatic atrial fibrillation. Cardiology. 1997;88:563–8.CrossRefPubMed

30.

Moon J, Rim SJ, Cho IJ, et al. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function. Clin Exp Hypertens. 2010;32:540–6.CrossRefPubMed

31.

Silvet H, Young-Xu Y, Walleigh D, et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol. 2003;92:1124–7.CrossRefPubMed

32.

Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail. 2000;6:92–6.CrossRefPubMed

33.

Ohta Y, Shimada T, Yoshitomi H, et al. Drop on plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol. 2001;17:415–20.PubMed

34.

Lee SH, Jung JH, Choi SH, et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J. 2006;70:100–4.CrossRefPubMed

35.

Sadanaga T, Kohsaka S, Mitamura H, et al. Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation. Heart Vessels. 2011;26:530–5.CrossRefPubMed

36.

Sakai K, Shibazaki K, Kimura K, et al. Brain natriuretic peptide as a predictor of cardioembolism in acute ischemic stroke patients: brain natriuretic peptide stroke prospective study. Eur Neurol. 2013;69:246–51.CrossRefPubMed

37.

Okada Y, Shibazaki K, Kimura K, et al. Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation. J Neurol Sci. 2011;301:86–9.CrossRefPubMed

38.

Ayirala S, Kumar S, O’Sullivan DM, et al. Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011;24:499–505.CrossRefPubMed

39.

Kim MN, Kim SA, Choi JI, et al. Improvement of predictive value for thromboembolic risk by Incorporating left atrial functional parameters in the CHADS2 and CHA2DS2-VAScs scores. Int Heart J. 2015;56:286–92.CrossRefPubMed

40.

Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts—implications for echocardiographic examination. Circulation. 1997;96:3112–5.CrossRefPubMed

41.

Bilge M, Guler N, Eryonucu B, et al. Does acute-phase beta blockade reduce left atrial appendage function in patients with chronic nonvalvular atrial fibrillation? J Am Soc Echocardiogr. 2001;14:194–9.CrossRefPubMed

42.

Daoud EG, Marcovitz P, Knight BP, et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. Circulation. 1999;99:3024–7.CrossRefPubMed

43.

Tsai LM, Chen JH, Lin LJ, et al. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 1997;80:897–900.CrossRefPubMed

44.

Ansari A, Maron BJ. Spontaneous echo contrast and thromboembolism. Hosp Pract. 1997;32:109–11.CrossRef

Title: Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function
Authors: Masahiko Harada
Satoshi Tabako
Yuichiro Fujii
Yuichi Takarada
Kyoko Hayashi
Hiroshi Ohara
Fumihiko Hara
Takanori Ikeda
Publication date: 01-06-2018
Publisher: Springer Japan
Published in: Journal of Echocardiography / Issue 2/2018
Print ISSN: 1349-0222
Electronic ISSN: 1880-344X
DOI: https://doi.org/10.1007/s12574-017-0362-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function

Abstract

Background

Methods and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2018

Delayed cardiac tamponade by loculated pericardial hematoma

Associations between left ventricular diastolic function and right ventricular function in patients with and without preserved left ventricular ejection fraction

A rare cause of tricuspid regurgitation

Successful percutaneous coronary intervention significantly improves coronary sinus blood flow as assessed by transthoracic echocardiography

Evaluation of left ventricular diastolic function: state of the art after 35 years with Doppler assessment

Systemic embolism from bilateral atrial myxomas